Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CRDF will decline by -13.41% over the next 2 Weeks and hit $1.08 by Wednesday, July 22, 2026. In that time frame, CRDF's share price is expected to range between $0.94 and $1.23.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 22, 2026 | 0.94 | 1.08 | 1.23 |
| Jul 21, 2026 | 1.02 | 1.14 | 1.30 |
| Jul 20, 2026 | 0.98 | 1.12 | 1.26 |
| Jul 17, 2026 | 1.06 | 1.19 | 1.35 |
| Jul 16, 2026 | 1.06 | 1.21 | 1.35 |
| Jul 15, 2026 | 1.03 | 1.18 | 1.32 |
| Jul 14, 2026 | 1.08 | 1.24 | 1.38 |
| Jul 13, 2026 | 1.07 | 1.22 | 1.36 |
| Jul 10, 2026 | 1.14 | 1.29 | 1.43 |
| Jul 9, 2026 | 1.15 | 1.30 | 1.44 |
CRDF shares rose +5.60% in Thursday, July 9, 2026's trading session, rising from a previous close of $1.25 to move at $1.32. The stock demonstrated notable intraday movement (see CRDF's key stats for a full breakdown), fluctuating between $1.27 and $1.34, a +5.93% trading range. While recent weeks have seen some volatility, CRDF has managed to secure a +9.09% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 956.35K shares changing hands, 49.27K more than the previous session. This amounted to $1.26M in total market activity.
Will CRDF Continue Its Downward Trend?
According to analyst ratings and projections for CRDF, Cardiff Oncology, Inc. shares are anticipated to decrease by -7.12%, potentially reaching $1.23 per share by July 22, 2026. Short-term technical indicators currently suggest a neutral sentiment for CRDF. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the CRDF stock forecast, now is not the best time to buy CRDF stock because its current trading price is +21.95% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CRDF covering social and institutional perspectives.
CRDF Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CRDF's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 45.01% to 49.37%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 44.79%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 45.80%, maintains a neutral outlook for the long term. Insights into CRDF's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Cardiff Oncology Short-Term Forecasts
CRDF Forecast For Next 5 Days
Our algorithm anticipates Cardiff Oncology (CRDF) stock could hit $1.18 by Jul 16, 2026. This represents a -10.51% fall from today's price, following a -2.09% change over the past five days.
CRDF Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Cardiff Oncology, Inc. (CRDF) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.15, which would mean a -12.88% decrease from the current price of $1.32. Projections for this period range from a high of $1.42 to a low of $0.85.
CRDF Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Cardiff Oncology's price over the next three months point to a rise. CRDF stock is expected to peak at $7.44 on Sep 29, 2026 after potentially dipping to $4.74 on Aug 18, 2026. On average, CRDF is likely to trade around $5.92 in the coming 90 days.
Cardiff Oncology Stock Forecast 2025
Based on our predictive models, Cardiff Oncology (CRDF) is expected to trade between $2.43 and $7.44 throughout 2026. This would result in an average price of $5.80, potentially offering investors a +339.39% return from current levels.
Cardiff Oncology, Inc. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Cardiff Oncology, Inc. (CRDF) is positioned to show a strong performance in July 2026. The price is predicted to move between $5.67 and $6.76, settling at an average of $6.26. This could translate to a +374.24% gain.
August 2026
Based on current market signals, Cardiff Oncology, Inc. is projected to trend august 2026. We forecast a trading range from $4.74 to $5.89, with a likely average price of $5.35. Investors could expect a potential return of +305.30%.
September 2026
Our predictive algorithms indicate Cardiff Oncology, Inc. stock may see a shift in September 2026. The expected range spans $4.93–$7.44, with an average target of $5.88. This represents a positive outlook and a possible gain of +345.45%.
October 2026
Analyzing established trends, Cardiff Oncology, Inc. looks set to move in October 2026. Projections place the stock between $4.70 and $7.40, averaging around $6.55. This suggests a +396.21% gain from current levels.
November 2026
Market indicators suggest Cardiff Oncology, Inc. could experience notable changes during November 2026. Prices could fluctuate within $2.45 to $6.15, with a midpoint forecast of $5.01. The stock might deliver a +279.55% gain.
December 2026
Forecasting for December 2026, models estimate that Cardiff Oncology, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $2.43 and $6.60, averaging $5.82. This signals a positive trajectory with potential returns around +340.91%.
January 2027
According to our latest forecast models, Cardiff Oncology, Inc. (CRDF) is positioned to show a strong performance in January 2027. The price is predicted to move between $0.82 and $6.40, settling at an average of $5.33. This could translate to a +303.79% gain.
February 2027
Based on current market signals, Cardiff Oncology, Inc. is projected to trend february 2027. We forecast a trading range from $0.00 to $5.48, with a likely average price of $5.06. Investors could expect a potential return of +283.33%.
March 2027
Our predictive algorithms indicate Cardiff Oncology, Inc. stock may see a shift in March 2027. The expected range spans $0.00–$6.02, with an average target of $5.76. This represents a positive outlook and a possible gain of +336.36%.
April 2027
Analyzing established trends, Cardiff Oncology, Inc. looks set to move in April 2027. Projections place the stock between $0.00 and $4.52, averaging around $3.63. This suggests a +175.00% gain from current levels.
May 2027
Market indicators suggest Cardiff Oncology, Inc. could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $3.83, with a midpoint forecast of $3.42. The stock might deliver a +159.09% gain.
June 2027
Forecasting for June 2027, models estimate that Cardiff Oncology, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $4.04, averaging $3.09. This signals a positive trajectory with potential returns around +134.09%.
July 2027
According to our latest forecast models, Cardiff Oncology, Inc. (CRDF) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $3.89, settling at an average of $3.18. This could translate to a +140.91% gain.
CRDF's history of dividends and stock splits also plays a role in long-term investor confidence.